Purpose: HCV genotyping helps in tailoring treatment plans for Hepatitis C. The genotype can influence the choice of antiviral therapy and its duration.
Method: The test involves PCR amplification to detect and identify the specific genetic type of the Hepatitis C virus from a blood sample.

Risk: The test itself is generally low-risk as it is performed on a blood sample. The primary risk involves the risk of discomfort or minor bleeding at the puncture site.
Pre-Test Considerations: No specific risk factors are usually associated with the test. However, it's crucial for the patient to disclose any medications or conditions that might affect the test results.

Genotype: There isn't a "normal" range for genotypes, as the results will identify the specific genotype of the virus present. The genotypes of Hepatitis C are categorized into several types (e.g., 1, 2, 3, 4, 5, 6) and their subtypes.

Genotype Identification: The test will report the specific genotype of HCV, which helps in determining the most effective treatment plan. For instance, genotype 1 is the most common in the U.S. and often requires different treatment compared to genotype 2 or 3.
Impact on Treatment: Different genotypes may respond differently to antiviral medications, and some genotypes may have a higher or lower likelihood of achieving a sustained virologic response (SVR).

Type: Blood sample (usually collected from a vein in the arm).
Preparation: No special preparation is generally required, but fasting or specific instructions might be provided by the healthcare provider.